Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches
Explore the latest advances in non-hydroxamate HDAC6 inhibitors, their medicinal chemistry, and therapeutic potential for cancer and neurodegenerative diseases.